Katherine Luzuriaga, M.D.
Director and PI, UMCCTS;
Vice Provost, Clinical and Translational Research;
Professor, Molecular Medicine, Pediatrics, and Medicine
University of Massachusetts Medical School
In July 2010, the University of Massachusetts received a $20 million NIH Clinical and Translational Science Award (CTSA) to create the UMass Center for Clinical and Translational Science (UMCCTS), an academic home for clinical and translational science. The goals of the UMCCTS are: 1) To accelerate the translation of basic discoveries into practical, cost effective solutions that improve human health; and 2) To develop and support the next generation of leaders in clinical and translational research.
Over the last 5 years, we have worked hard to build an ecosystem that supports the translation of UMass discoveries into products for clinical use. By continuing to build capacity for clinical and translational research across the five UMass campuses (Amherst, Boston, Dartmouth, Lowell, and Worcester), we will develop products that improve the health of citizens of the Commonwealth of Massachusetts and the world, while also generating important economic benefits for the State. We encourage you to browse through our site to learn more about what UMCCTS has to offer.